These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

538 related articles for article (PubMed ID: 29166502)

  • 21. Short-term prophylaxis in patients with angioedema due to C1-inhibitor deficiency undergoing dental procedures: An observational study.
    Zanichelli A; Ghezzi M; Santicchia I; Vacchini R; Cicardi M; Sparaco A; Donati G; Ranìa V; Busa A
    PLoS One; 2020; 15(3):e0230128. PubMed ID: 32163480
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Successful management of hereditary angioedema during tonsillectomy: a case report.
    Hermans C; Vander Vorst S; Lambert C
    Blood Coagul Fibrinolysis; 2012 Mar; 23(2):155-7. PubMed ID: 22193715
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recombinant human C1 esterase inhibitor (Conestat alfa) for prophylaxis to prevent attacks in adult and adolescent patients with hereditary angioedema.
    Valerieva A; Caccia S; Cicardi M
    Expert Rev Clin Immunol; 2018 Sep; 14(9):707-718. PubMed ID: 30021471
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nanofiltered C1 esterase inhibitor (human) for the treatment of acute attacks of hereditary angioedema: an open-label trial.
    Riedl MA; Hurewitz DS; Levy R; Busse PJ; Fitts D; Kalfus I
    Ann Allergy Asthma Immunol; 2012 Jan; 108(1):49-53. PubMed ID: 22192966
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical features of genetically characterized types of hereditary angioedema with normal C1 inhibitor: a systematic review of qualitative evidence.
    Bork K; Machnig T; Wulff K; Witzke G; Prusty S; Hardt J
    Orphanet J Rare Dis; 2020 Oct; 15(1):289. PubMed ID: 33059692
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current management options for hereditary angioedema.
    Bork K
    Curr Allergy Asthma Rep; 2012 Aug; 12(4):273-80. PubMed ID: 22729959
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase II study results of a replacement therapy for hereditary angioedema with subcutaneous C1-inhibitor concentrate.
    Zuraw BL; Cicardi M; Longhurst HJ; Bernstein JA; Li HH; Magerl M; Martinez-Saguer I; Rehman SM; Staubach P; Feuersenger H; Parasrampuria R; Sidhu J; Edelman J; Craig T
    Allergy; 2015 Oct; 70(10):1319-28. PubMed ID: 26016741
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Subcutaneous C1-esterase inhibitor to prevent hereditary angioedema attacks: Safety findings from the COMPACT trial.
    Li HH; Mycroft S; Christiansen S; Wood DN; Feuersenger H; Pawaskar D; Jacobs I
    Allergy Asthma Proc; 2018 Sep; 39(5):365-370. PubMed ID: 30107868
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frequent life-threatening laryngeal attacks in two Croatian families with hereditary angioedema due to C1 inhibitor deficiency harbouring a novel frameshift mutation in SERPING1.
    Karadža-Lapić L; Korošec P; Šilar M; Košnik M; Cikojević D; Lozić B; Rijavec M
    Ann Med; 2016 Nov; 48(7):485-491. PubMed ID: 27187751
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nanofiltered C1 esterase inhibitor for treatment of laryngeal attacks in patients with hereditary angioedema.
    Riedl MA; Lumry WR; Li HH; Craig TJ; Fitts D; Kalfus I; Uknis ME
    Am J Rhinol Allergy; 2013; 27(6):517-21. PubMed ID: 24274230
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnosis and treatment of hereditary angioedema.
    Canonica GW; Rossi O
    Panminerva Med; 2012 Sep; 54(3):241-53. PubMed ID: 22801442
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnosis and management of hereditary angioedema.
    Johnston DT
    J Am Osteopath Assoc; 2011 Jan; 111(1):28-36. PubMed ID: 21258014
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hereditary angioedema with normal C1 inhibitor: clinical characteristics and treatment response with plasma-derived human C1 inhibitor concentrate (Berinert
    Bouillet L; Boccon-Gibod I; Gompel A; Floccard B; Martin L; Blanchard-Delaunay C; Launay D; Fain O
    Eur J Dermatol; 2017 Apr; 27(2):155-159. PubMed ID: 28251901
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Definition and classification of hereditary angioedema.
    Proper SP; Lavery WJ; Bernstein JA
    Allergy Asthma Proc; 2020 Nov; 41(Suppl 1):S03-S07. PubMed ID: 33109317
    [TBL] [Abstract][Full Text] [Related]  

  • 35. C1 esterase inhibitor concentrate in 1085 Hereditary Angioedema attacks--final results of the I.M.P.A.C.T.2 study.
    Craig TJ; Bewtra AK; Bahna SL; Hurewitz D; Schneider LC; Levy RJ; Moy JN; Offenberger J; Jacobson KW; Yang WH; Eidelman F; Janss G; Packer FR; Rojavin MA; Machnig T; Keinecke HO; Wasserman RL
    Allergy; 2011 Dec; 66(12):1604-11. PubMed ID: 21884533
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Therapeutic approach of hereditary angioedema].
    Chagas Kde N; Arruk VG; Andrade ME; Vasconcelos Dde M; Kirschfink M; Duarte AJ; Grumach AS
    Rev Assoc Med Bras (1992); 2004; 50(3):314-9. PubMed ID: 15499486
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prospective study of C1 esterase inhibitor in the treatment of successive acute abdominal and facial hereditary angioedema attacks.
    Wasserman RL; Levy RJ; Bewtra AK; Hurewitz D; Craig TJ; Kiessling PC; Keinecke HO; Bernstein JA
    Ann Allergy Asthma Immunol; 2011 Jan; 106(1):62-8. PubMed ID: 21195947
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A single nucleotide deletion at the C1 inhibitor gene as the cause of hereditary angioedema: insights from a Brazilian family.
    Ferraro MF; Moreno AS; Castelli EC; Donadi EA; Palma MS; Arcuri HA; Lange AP; Bork K; Sarti W; Arruda LK
    Allergy; 2011 Oct; 66(10):1384-90. PubMed ID: 21623829
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hereditary angioedema with normal C1-INH with versus without specific F12 gene mutations.
    Bork K; Wulff K; Witzke G; Hardt J
    Allergy; 2015 Aug; 70(8):1004-12. PubMed ID: 25952149
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hereditary angioedema caused by missense mutations in the factor XII gene: clinical features, trigger factors, and therapy.
    Bork K; Wulff K; Hardt J; Witzke G; Staubach P
    J Allergy Clin Immunol; 2009 Jul; 124(1):129-34. PubMed ID: 19477491
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.